LiveMetric has announced that it has received FDA 510 (k) clearance for its watch-like blood pressure monitor, LiveOne.
The cuffless device uses a sensor array placed above the radial artery to create a pressure wave. The waveform is analyzed by an algorithm to determine systolic and diastolic blood pressure and pulse rate. According to The FDA’s 510 (k) database, LiveOne, with a clear radial pulse intended for use in clinical settings for patients 27 years of age or older.
The Luxembourg-based company says LiveOne monitoring services will soon be available for people with high blood pressure or cardiovascular disease through healthcare, insurers and self-insured employers.
Kelly Benning, vice president of Livemetric, said in a statement, “The LiveOne device is designed to address the global epidemic of high blood pressure by providing meaningful, deeply personalized health information to patients and providers so that action can be taken in real time.”
“As easy as wearing a watch, the LiveOne device will change how high blood pressure and cardiovascular disease are managed and treated by offering people a thorough understanding of how their lifestyle, behavior and medications affect their blood pressure. We are focused on bringing this. করছি Millions of users across our customer-based channels. “
Another company behind the watch-like blood pressure device is Actia, which has announced that it was Received a European CE mark in early 2021. The Swiss startup raised এ 17.5 million in series A funding in November. Although it is not yet commercially available in the United States, Actia announced in January that it would conduct a study with Brigham and Women’s Hospital in Boston.
Omron Health Care In 2018 it first received FDA clearance for its HeartGuide wearable blood pressure monitor.
Meanwhile, Samsung has included Blood pressure monitoring on its Galaxy smartwatches in countries where it has regulatory approval. Although ECG tracking has been cleared by the FDA, blood pressure monitoring is not available in the United States.
Apple is interested in monitoring blood pressure for its watches. However, as The technology is not expected to be ready by 2024, Bloomberg reported in April.